Therapeutic effects of tyroserleutide on lung metastasis of human hepatocellular carcinoma SK-HEP-1 and its mechanism affecting ICAM-1 and MMP-2 and -9 | Zendy

Xuchun Che | Zendy; Rong Lu | Zendy; Zheng Fu | Zendy; Yajun Sun | Zendy; Zhifeng Zhu | Zendy; JinPing Li | Zendy; Song Wang | Zendy; Jing Jia | Zendy; Qing Wang | Zendy; Zhi Yao | Zendy

Open Access

Therapeutic effects of tyroserleutide on lung metastasis of human hepatocellular carcinoma SK-HEP-1 and its mechanism affecting ICAM-1 and MMP-2 and -9

Author(s) -

Xuchun Che,

Rong Lu,

Zheng Fu,

Yajun Sun,

Zhifeng Zhu,

JinPing Li,

Song Wang,

Jing Jia,

Qing Wang,

Zhi Yao

Publication year - 2018

Publication title -

drug design development and therapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.964

H-Index - 64

ISSN - 1177-8881

DOI - 10.2147/dddt.s177126

Subject(s) - metastasis , western blot , cancer research , hepatocellular carcinoma , in vivo , in vitro , blot , biology , cell culture , carcinoma , microbiology and biotechnology , pathology , medicine , cancer , gene , biochemistry , genetics

Tyroserleutide (YSL) inhibits the growth and metastasis of human hepatocellular carcinoma (HCC). This paper studied the effect of YSL on metastasis of human HCC and investigated its mechanisms.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research